RECRUITING

Prospective Measurement of Normal Venous Sinus Pressures

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research is to document normal intracranial venous sinus pressures. Participants who need to have a cerebral angiogram to evaluate a medical problem not related to Idiopathic Intracranial Hypertension (IIH) will be invited to participate. Participation in this research will not require any extra visits. The intervention will take place in the interventional radiology suite when the subject has an angiogram. IIH is a condition that causes increased pressure in the brain in the absence of a tumor or other diseases that may be causing symptoms. Symptoms include headaches and visual disturbances not explained by other things. In IIH there is a narrowing in the sinuses of the brain that causes the increased pressure.

Official Title

Venous Sinus Pressures in Normal Individuals

Quick Facts

Study Start:2020-01-13
Study Completion:2025-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03948971

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Candidates for elective cerebral arteriography
  1. * All patients with active, or a history of, intracranial venous pathology (arteriovenous malformation, arteriovenous fistulae, idiopathic intracranial hypertension, venous sinus thrombosis).
  2. * Patients with severe daily headaches or symptoms of idiopathic intracranial hypertension will also be excluded.
  3. * Body mass index \> 35.
  4. * Known diagnosis of heart failure or pulmonary hypertension.
  5. * Pregnant women will be excluded due to the radiation risk associated with Angiogram and Venogram.

Contacts and Locations

Study Contact

Kimberly Hawley
CONTACT
336-716-4031
khawley@wakehealth.edu
Kyle Fargen, MD
CONTACT
kfargen@wakehealth.edu

Principal Investigator

Kyle Fargen, MD
PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences

Study Locations (Sites)

Wake Forest Univesity Health Sciences
Winston-Salem, North Carolina, 27157
United States

Collaborators and Investigators

Sponsor: Wake Forest University Health Sciences

  • Kyle Fargen, MD, PRINCIPAL_INVESTIGATOR, Wake Forest University Health Sciences

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-01-13
Study Completion Date2025-05

Study Record Updates

Study Start Date2020-01-13
Study Completion Date2025-05

Terms related to this study

Keywords Provided by Researchers

  • cerebral arteriography

Additional Relevant MeSH Terms

  • Intracranial Venous Pressures